financetom
Business
financetom
/
Business
/
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
Nov 20, 2024 7:41 PM

05:02 PM EST, 11/20/2024 (MT Newswires) -- (Updates the stock change in the last paragraph.)

Nvidia ( NVDA ) reported fiscal Q3 non-GAAP earnings late Wednesday of $0.81 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.75 excluding some items.

Revenue in the three months ended Oct. 27 rose to $35.08 billion from $18.12 billion a year earlier.

Analysts surveyed by FactSet expected $33.17 billion.

The company expects fiscal Q4 revenue of $37.5 billion, plus or minus 2%. Analysts expect $37.09 billion.

Nvidia ( NVDA ) shares fell 0.7% in after-hours activity, paring earlier losses.

Price: 144.81, Change: -1.08, Percent Change: -0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta should give users free option without targeted ads, EU privacy watchdog says
Meta should give users free option without targeted ads, EU privacy watchdog says
Apr 17, 2024
BRUSSELS (Reuters) - Meta Platforms ( META ) and other large online platforms should give users an option to use their services for free without targeted advertising, EU privacy watchdog the European Data Protection Board said on Wednesday. The EDPB's opinion came after it was asked by national privacy regulators in the Netherlands, Norway and Germany to look into consent...
Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise
Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise
Apr 17, 2024
11:23 AM EDT, 04/17/2024 (MT Newswires) -- Celldex Therapeutics ( CLDX ) said Wednesday that enrollment of patients has been completed in its phase 2 clinical study of barzolvolimab for the treatment of cold urticaria and symptomatic dermographism, the two most common types of chronic inducible urticarial. Cold urticaria symptoms include itching, burning wheals and angioedema when skin is exposed...
Travelers Misses Fiscal First-Quarter Views as Catastrophe Losses Jump
Travelers Misses Fiscal First-Quarter Views as Catastrophe Losses Jump
Apr 17, 2024
11:24 AM EDT, 04/17/2024 (MT Newswires) -- Shares of Travelers (TRV) tumbled on Wednesday after the property and casualty insurer reported weaker-than-expected results for the first quarter amid higher catastrophe losses. Earned premium rose to $10.13 billion from $8.85 billion a year ago but missed the average analyst estimate of $10.21 billion in a Capital IQ poll. Shares of Travelers...
Volkswagen Tennessee plant workers vote on UAW membership
Volkswagen Tennessee plant workers vote on UAW membership
Apr 17, 2024
(Reuters) - After a series of victories against the Detroit Three automakers last fall, United Auto Workers (UAW) President Shawn Fain is now trying to use his influence to organize other U.S. auto factories that have stayed out of the union's ambit. The UAW has tried and failed for years to organize nonunion U.S. auto factories, most of them built...
Copyright 2023-2026 - www.financetom.com All Rights Reserved